Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Respecting Choices® Becomes First Advance Care Planning Program to be Approved as an Evidence-Based Program by the Administration for Community Living (ACL)


LA CROSSE, Wis., Feb. 20, 2020 /PRNewswire/ -- The country's most established program for Advance Care Planning (ACP) practice and capacity building, Respecting Choices guides organizations and communities worldwide to effectively implement and sustain evidence-based systems that provide person-centered care.

"We're honored to be the first advance care planning program approved as an evidence-based program by the Administration for Community Living," said Dr. Carole Montgomery, MD, Executive Medical Director at Respecting Choices. "Respecting Choices has been collecting evidence for 20+ years and it has all been leading up to this moment. The groups we work with?hundreds of health systems, organizations and communities?recognize the significant importance of advance care planning but are challenged by lack of resources to meet demand. Organizations and communities across the country will now have a tremendous opportunity to implement and effectively scale our sustainable, evidence-based advance care planning program."

About Respecting Choices
Respecting Choices has two programs that work together to embed person-centered decision making as a standard: Advance Care Planning (ACP) and Shared Decision Making in Serious Illness (SDMSI).  These programs have been used in over 330 organizations worldwide and validated in 33 research publications, providing a robust foundation of practical experience and proven effectiveness at improving outcomes, satisfaction and cost. Respecting Choices has developed curricula and materials to support ACP conversations at every stage of health, certified thousands of multidisciplinary professionals to facilitate these conversations, and consulted with hundreds of organizations, communities, and states on the development of systems to support ACP.

Contact:
Respecting Choices®
Matthew Isbell
608.473.3083
[email protected]  

SOURCE Respecting Choices


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: